Work

Genotype Correlations With Blood Pressure and Efficacy From a Randomized Phase III Trial of Second-Line Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma

Year: 2015

Type: article

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2015.02.007

Authors: Bernard Escudier, Brian I. Rini, Robert J. Motzer, Jamal Tarazi, Sinil Kim, Xin Huang, Brad Rosbrook, Patricia A. English, A. Katrina Loomis, J. Andrew Williams

Institutions: Institut Gustave Roussy, Cleveland Clinic, Memorial Sloan Kettering Cancer Center, Pfizer (United States)

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Pfizer

OpenAlex ID: W2014433798

FWCI: 4.277

Cites: 45

Cited by: 34

Related to: 10